Group items tagged

Colonis, a subsidiary company of the Clinigen Group has received the Medicines and Healthcare products Regulatory Agency (MHRA) approval for Melatonin 1mg/ml Oral Solution for sleep onset insomnia in children and adolescents aged 6-17 years with attention-deficit hyperactivity disorder (ADHD). Clinical evidence demonstrates that Melatonin has the potential to decrease sleep latency and increase sleep efficiency in children with ADHD and chronic sleep onset insomnia. Children with ADHD are statistically more likely to have sleep onset insomnia than non-ADHD children. The prevalence of sleep onset insomnia in children with ADHD ranges from 25%-50%. Sleep onset insomnia in children with ADHD can affect their mood, attention, behaviour and school performance. Henno Welgemoed, Director of Medical Affairs at Colonis said: "We welcome the MHRA's approval for a condition that negatively affects the quality of life for children and adolescents diagnosed with ADHD and increases the burden for support networks."

Addiction is a difficult disease to deal with, both for the person who is struggling with it and for their loved ones. If you have a family member who is battling addiction, it can be hard to know what to do to help them. The good news is that there are things you can do to support your loved ones and improve their chances of recovery. In this blog post, we will discuss six ways that families can help their loved ones struggling with addiction. 1. EDUCATE YOURSELF ABOUT ADDICTION AND WHAT YOU CAN DO TO HELP To truly be able to help a family member who is struggling with addiction, you first need to educate yourself about the disease. This means learning about what causes addiction, how it affects the mind and body, and what you can do to support your loved one through their recovery journey. There are plenty of resources available online and at your local library that can help you learn more about addiction. You can also attend support groups for families of addicts, which can provide valuable information and emotional support. If you take the time to educate yourself about addiction, you'll be in a much better position to help your loved one through their struggle.

This article aims to shed light on the different types of bronchitis in children, their triggers, and strategies to avoid or mitigate these factors.

An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In the mid-stage trial, 47 per cent of the patients that were given the two drugs Tafinlar and Mekinist saw their tumours shrink, far above a rate of 11 per cent in a comparative group of participants on standard chemotherapy, the drugmaker said on Monday, June 6. The participants, aged one to 17 years, were suffering from low-grade gliomas (LGG), the most common childhood brain cancer. The trial only included those who were found to have a mutation known as BRAF V600, a genetic contributor in about 15 per cent to 20 per cent of paediatric LGG cases. Among further results of the trial with 110 participants, the median time without disease progression was 20.1 months for those given the Novartis drug combo, compared to 7.4 months on chemotherapy. The new oral treatment candidate also caused less severe side effects than burdensome chemotherapy.